Question 1

What is Astellas Pharma?

Accepted Answer

Astellas Pharma is a Company.

Question 2

How often does Astellas Pharma appear in global news?

Accepted Answer

Tracked across 6 news events drawn from 113 articles.

Question 3

When was Astellas Pharma first tracked by Ergen?

Accepted Answer

First tracked on Apr 20, 2026.

Question 4

When was Astellas Pharma last mentioned in news?

Accepted Answer

Last active on Aug 07, 2026.

Question 5

What is Astellas Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: -2 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Astellas Pharma in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 6 events.

Question 7

What is the most recent event involving Astellas Pharma?

Accepted Answer

Trump's Medicaid Drug Price Pilot (Apr 20, 2026, 6 articles).

Question 8

Who is Astellas Pharma most connected to?

Accepted Answer

Top relationships: United States — Food and Drug Administration, United States — Food and Drug Administration.

Question 9

How did the "Trump's Medicaid Drug Price Pilot" event impact Astellas Pharma?

Accepted Answer

Astellas Pharma is one of the few mid-sized drug companies that confirmed its application to the United States — Medicaid pilot program, viewing it as a constructive path forward in a complex policy environment.

Question 10

How did the "Lupin gets US FDA approval" event impact Astellas Pharma?

Accepted Answer

Astellas Pharma is the manufacturer of the reference listed drug Xtandi Tablets, to which Lupin (company)'s Enzalutamide Tablets were found bioequivalent. This approval could introduce competition for Astellas Pharma's product.

Question 11

How did the "Nikkei 225 Reaches All-Time Highs" event impact Astellas Pharma?

Accepted Answer

Astellas Pharma's stock declined, showing a negative performance.

Question 12

How did the "Japanese stocks volatile amid Middle East tensions" event impact Astellas Pharma?

Accepted Answer

Astellas Pharma gained almost 5% on one day, reflecting positive sentiment.

Question 13

How did the "Sangamo Therapeutics Explores Strategic Alternatives" event impact Astellas Pharma?

Accepted Answer

Astellas Pharma has licensed MiNK Therapeutics' STAC-BBB platform for neurological targets, indicating a past business relationship that could be affected by Sangamo's strategic review.

Question 14

How did the "GATA6 loss drives colorectal cancer metastasis" event impact Astellas Pharma?

Accepted Answer

Provided funding via Astellas Foundation.

Question 15

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.